Welcome to the Miller Lab at the Medical College of Wisconsin Cancer Center. Our lab is focused on understanding the causes of drug resistance in breast cancer and the discovery of new treatment strategies.
Epithelial-Mesenchymal Transition is Associated with Altered Immune Composition and Cytotoxic Function in Triple-Negative Breast Cancer.
Hanxu Lu, Meisam Bagheri, Fred W Kolling, Lucas A Salas, Xiaofeng Wang, Todd W Miller, Diwakar R Pattabiraman, Brock Christensen.
bioRxiv [Preprint]. 2025 Oct 23:2025.10.22.683714. doi: 10.1101/2025.10.22.683714.
Combined Radiation and Endocrine Therapies Elicit Benefit in ER+ Breast Cancer.
Anneka L Johnson, Steven Tau, Austin M Sloop, Tianyuan Dai, Alyssa M Roberts, Patricia Muskus, Alexa Warren, Sierra A Kleist, Riley A Hampsch, Julie M Jorns, Rongxiao Zhang, Lesley A Jarvis, Todd W Miller.
Cancers (Basel). 2025 Jun 9;17(12):1921. doi: 10.3390/cancers17121921.
Reply to: "Comments on the paper 'Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer' by Y. Chen et al.".
Youdinghuan Chen, Lucas A Salas, Jonathan D Marotti, Nicole P Jenkins, Chao Cheng, Todd W Miller, Arminja N Kettenbach, Brock C Christensen.
Int J Cancer. 2025 Aug 1;157(3):590-591. doi: 10.1002/ijc.35434. Epub 2025 Apr 18.